The University of Southampton
University of Southampton Institutional Repository

Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children

Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children
Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children

Protective antibody responses to human immunodeficiency virus (HIV)-1 infection evolve only in a fraction of infected individuals by developing broadly neutralizing antibodies (bnAbs) and/or effector functions such as antibody-dependent cellular cytotoxicity (ADCC). HIV-1 chronically infected adults and children on combination antiretroviral therapy (cART) showed a reduction in ADCC activity and improvement in HIV-1 specific neutralizing antibody (nAb) responses. Early initiation of cART in infected adults is found to be beneficial in reducing the viral load and delaying disease progression. Herein, we longitudinally evaluated the effect of cART on HIV-1 specific plasma ADCC and nAb responses in a cohort of 20 perinatally HIV-1 subtype-C infected infants and children ≤2 years of age, pre-cART and up to 1 year post-cART initiation. Significant reductions in HIV-1 specific plasma ADCC responses to subtype-C and subtype-B viruses and improvement in HIV-1 neutralization were observed in HIV-1 infected children 1 year post-cART initiation. A positive correlation between reduction in viral load and the loss of ADCC response was observed. This study provides information aiding the understanding of the effects of early initiation of cART on antibody effector functions and viral neutralization in HIV-1 infected children, which needs to be further evaluated in large cohorts of HIV-1 infected children on cART to plan future intervention strategies.

Anti-HIV Agents/therapeutic use, Antibodies, Neutralizing/blood, Antibody-Dependent Cell Cytotoxicity/drug effects, Antiretroviral Therapy, Highly Active, Child, Preschool, Cohort Studies, Dideoxynucleosides/therapeutic use, Drug Combinations, HIV Antibodies/blood, HIV Infections/drug therapy, HIV-1/classification, Humans, Infant, Lamivudine/therapeutic use, Lopinavir, Ritonavir, Viral Load, Zidovudine/therapeutic use
0022-1317
1289-1299
Kumar, Sanjeev
72adbe62-7c8b-4430-aab6-6e54e94b2a91
Batra, Himanshu
f8755e80-38a0-41bd-815b-1db071283f2e
Singh, Swarandeep
3b6a2cb8-67ab-4b93-a648-cca8394bcba8
Chawla, Himanshi
07b9e983-4c35-4314-999d-fe3222a6c03b
Singh, Ravinder
4f8eac9d-8675-4603-ba25-796eec5f003f
Katpara, Sanket
8d83d2d8-b35a-43ec-995a-cbb29b288f67
Hussain, Abdul Wahid
42bf063f-332b-4edf-bf09-4fee9f8720c4
Das, Bimal Kumar
dc79149c-9b26-44f1-8b6f-4b6faa1540e6
Lodha, Rakesh
cdfb40fa-c83b-4ec0-bfe2-33a589209a62
Kabra, Sushil Kumar
ba01266c-dc15-497d-8555-64e776d115ca
Luthra, Kalpana
40fc2436-ee10-4d8b-a414-70e7214a2bf2
Kumar, Sanjeev
72adbe62-7c8b-4430-aab6-6e54e94b2a91
Batra, Himanshu
f8755e80-38a0-41bd-815b-1db071283f2e
Singh, Swarandeep
3b6a2cb8-67ab-4b93-a648-cca8394bcba8
Chawla, Himanshi
07b9e983-4c35-4314-999d-fe3222a6c03b
Singh, Ravinder
4f8eac9d-8675-4603-ba25-796eec5f003f
Katpara, Sanket
8d83d2d8-b35a-43ec-995a-cbb29b288f67
Hussain, Abdul Wahid
42bf063f-332b-4edf-bf09-4fee9f8720c4
Das, Bimal Kumar
dc79149c-9b26-44f1-8b6f-4b6faa1540e6
Lodha, Rakesh
cdfb40fa-c83b-4ec0-bfe2-33a589209a62
Kabra, Sushil Kumar
ba01266c-dc15-497d-8555-64e776d115ca
Luthra, Kalpana
40fc2436-ee10-4d8b-a414-70e7214a2bf2

Kumar, Sanjeev, Batra, Himanshu, Singh, Swarandeep, Chawla, Himanshi, Singh, Ravinder, Katpara, Sanket, Hussain, Abdul Wahid, Das, Bimal Kumar, Lodha, Rakesh, Kabra, Sushil Kumar and Luthra, Kalpana (2020) Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children. The Journal of General Virology, 101 (12), 1289-1299. (doi:10.1099/jgv.0.001480).

Record type: Article

Abstract

Protective antibody responses to human immunodeficiency virus (HIV)-1 infection evolve only in a fraction of infected individuals by developing broadly neutralizing antibodies (bnAbs) and/or effector functions such as antibody-dependent cellular cytotoxicity (ADCC). HIV-1 chronically infected adults and children on combination antiretroviral therapy (cART) showed a reduction in ADCC activity and improvement in HIV-1 specific neutralizing antibody (nAb) responses. Early initiation of cART in infected adults is found to be beneficial in reducing the viral load and delaying disease progression. Herein, we longitudinally evaluated the effect of cART on HIV-1 specific plasma ADCC and nAb responses in a cohort of 20 perinatally HIV-1 subtype-C infected infants and children ≤2 years of age, pre-cART and up to 1 year post-cART initiation. Significant reductions in HIV-1 specific plasma ADCC responses to subtype-C and subtype-B viruses and improvement in HIV-1 neutralization were observed in HIV-1 infected children 1 year post-cART initiation. A positive correlation between reduction in viral load and the loss of ADCC response was observed. This study provides information aiding the understanding of the effects of early initiation of cART on antibody effector functions and viral neutralization in HIV-1 infected children, which needs to be further evaluated in large cohorts of HIV-1 infected children on cART to plan future intervention strategies.

This record has no associated files available for download.

More information

Published date: 1 December 2020
Keywords: Anti-HIV Agents/therapeutic use, Antibodies, Neutralizing/blood, Antibody-Dependent Cell Cytotoxicity/drug effects, Antiretroviral Therapy, Highly Active, Child, Preschool, Cohort Studies, Dideoxynucleosides/therapeutic use, Drug Combinations, HIV Antibodies/blood, HIV Infections/drug therapy, HIV-1/classification, Humans, Infant, Lamivudine/therapeutic use, Lopinavir, Ritonavir, Viral Load, Zidovudine/therapeutic use

Identifiers

Local EPrints ID: 453731
URI: http://eprints.soton.ac.uk/id/eprint/453731
ISSN: 0022-1317
PURE UUID: 79dc9a3d-0d1a-46f2-9005-b520b8b0b39a
ORCID for Himanshi Chawla: ORCID iD orcid.org/0000-0001-9828-6593

Catalogue record

Date deposited: 21 Jan 2022 17:41
Last modified: 17 Mar 2024 03:57

Export record

Altmetrics

Contributors

Author: Sanjeev Kumar
Author: Himanshu Batra
Author: Swarandeep Singh
Author: Himanshi Chawla ORCID iD
Author: Ravinder Singh
Author: Sanket Katpara
Author: Abdul Wahid Hussain
Author: Bimal Kumar Das
Author: Rakesh Lodha
Author: Sushil Kumar Kabra
Author: Kalpana Luthra

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×